相似文献
2
Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Hematol Oncol. 2018 Feb;36(1):93-97. doi: 10.1002/hon.2449. Epub 2017 Jun 22.
3
Clinical impact of serum survivin positivity and tissue expression of EBV-encoded RNA in diffuse large B-cell lymphoma patients treated with rituximab-CHOP.
Oncotarget. 2017 Feb 21;8(8):13782-13791. doi: 10.18632/oncotarget.14636.
4
Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
Pathol Res Pract. 2013 Aug;209(8):471-8. doi: 10.1016/j.prp.2013.04.014. Epub 2013 May 9.
5
Clinical outcome of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly in the rituximab era.
Cancer Sci. 2014 Sep;105(9):1170-5. doi: 10.1111/cas.12467. Epub 2014 Sep 8.
6
Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries.
Clin Cancer Res. 2014 May 1;20(9):2338-49. doi: 10.1158/1078-0432.CCR-13-3157. Epub 2014 Feb 28.
7
Clinical outcome of elderly patients with Epstein-Barr virus positive diffuse large B-cell lymphoma treated with a combination of rituximab and CHOP chemotherapy.
Am J Hematol. 2013 Sep;88(9):774-9. doi: 10.1002/ajh.23507. Epub 2013 Jul 23.
8
Impact of treatment variability and clinicopathological characteristics on survival in patients with Epstein-Barr-Virus positive diffuse large B cell lymphoma.
Br J Haematol. 2020 Apr;189(2):257-268. doi: 10.1111/bjh.16342. Epub 2020 Jan 20.
9
TET2 and LILRB1 mutations are frequent in Epstein-Barr virus-positive diffuse large B-cell lymphoma especially in elderly patients.
Cancer. 2023 May 15;129(10):1502-1512. doi: 10.1002/cncr.34698. Epub 2023 Feb 22.
10
Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Hum Pathol. 2015 May;46(5):716-24. doi: 10.1016/j.humpath.2015.01.011. Epub 2015 Feb 3.
Zotero 插件